Additionally, combining LINE-1 hypomethylation with other markers, such as RASSF1A hypermethylation in HCC or AIM1 methylation in melanoma, enhances prognostic accuracy and predicts early recurrence post-surgery. This evidence concerns the gene CRYBG1 and melanoma.